These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14006439)

  • 1. A toxicologic and hematologic evaluation of cyclophosphamide (Cytoxan) in experimental animals.
    WHEELER AG; DANSBY D; HAWKINS HC; PAYNE HG; WEIKEL JH
    Toxicol Appl Pharmacol; 1962 May; 4():324-43. PubMed ID: 14006439
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of the cytostatic endoxan and trisethyleniminobenzoquinone on the bone marrow and peripheral blood of the rat].
    BIERBRAUER U
    Folia Haematol (Frankf); 1961 Aug; 5():143-61. PubMed ID: 13869053
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of a leukaemia resistant to cyclophosphamide ('Cytoxan').
    LANE M; YANCEY ST
    Nature; 1960 Nov; 188():756-7. PubMed ID: 13758721
    [No Abstract]   [Full Text] [Related]  

  • 4. Some effects of cyclophosphamide (cytoxan) on normal mice and mice with L1210 leukemia.
    LANE M
    J Natl Cancer Inst; 1959 Dec; 23():1347-59. PubMed ID: 14413840
    [No Abstract]   [Full Text] [Related]  

  • 5. The effectiveness of cyclophosphamide (cytoxan) against well established transplanted rodent tumors.
    LANE M
    Cancer Res; 1960 Sep; 20():1269-73. PubMed ID: 13758722
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of cytoxan (cyclophosphamide) on wound healing.
    DESPREZ JD; KIEHN CL
    Plast Reconstr Surg Transplant Bull; 1960 Sep; 26():301-8. PubMed ID: 13722222
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigation of the activity of cytoxan against leukemia L1210 in mice.
    VENDITTI JM; HUMPHREYS SR; GOLDIN A
    Cancer Res; 1959 Oct; 19():986-95. PubMed ID: 13841661
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathology of the spread of L1210 leukemia in the central nervous system of mice and effect of treatment with Cytoxan.
    THOMAS LB; CHIRIGOS MA; HUMPHREYS SR; GOLDIN A
    J Natl Cancer Inst; 1962 Jun; 28():1355-89. PubMed ID: 13920822
    [No Abstract]   [Full Text] [Related]  

  • 9. Transplantable human tumors in experimental chemotherapy. The effects of Cytoxan on H.S. No. 1 and H.Ep No. 3 in the rat.
    TELLER MN; WOOLLEY GW
    Cancer Res; 1961 Aug; 21():881-4. PubMed ID: 13775794
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative studies on the effect of N,N',N''-triethylenethiophosphoramide (thio-TEPA) on human blood and bone marrow cells and on fibroblasts in vitro].
    ALBRECHT M; KRETSCHMER V
    Folia Haematol (Frankf); 1961 Aug; 5():272-80. PubMed ID: 13860164
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitumor activity of cytoxan.
    SUGIURA K; SCHMID FA; SCHMID MM
    Cancer Res; 1961 Nov; 21():1412-20. PubMed ID: 13918230
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of Cytoxan against intracerebrally and subcutaneously inoculated mouse lymphoid leukemia L1210.
    CHIRIGOS MA; HUMPHREYS SR; GOLDIN A
    Cancer Res; 1962 Feb; 22():187-95. PubMed ID: 13879017
    [No Abstract]   [Full Text] [Related]  

  • 13. MULTIPLE MYELOMA. STUDIES OF MOUSE PLASMA CELL TUMOR AND HUMAN MYELOMA RESPONSIVENESS TO CYCLOPHOSPHAMIDE (CYTOXAN).
    KORST DR; FRENKEL EP; NIXON JC
    Ann Intern Med; 1964 Feb; 60():217-30. PubMed ID: 14114442
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical and morphologic changes in a mast-cell neoplasm during treatment with cyclophosphamide.
    MENGEL CE; KELLY MG
    Cancer Res; 1961 Dec; 21():1545-50. PubMed ID: 14472639
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE EFFECT OF AMINOETHYLISOTHIURONIUM ON THE SPECIFIC ACTION OF SOME ANTINEOPLASTIC PREPARATIONS].
    LARIONOV LF; PLATONOVA GN; SPASSKAIA IG
    Biull Eksp Biol Med; 1964 May; 57():73-6. PubMed ID: 14220769
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical evaluation of a new alkylating agent: cytoxan (cyclophosphamide).
    COGGINS PR; RAVDIN RG; EISMAN SH
    Cancer; 1960; 13():1254-60. PubMed ID: 13694297
    [No Abstract]   [Full Text] [Related]  

  • 17. [INFLUENCE OF ALKYLATING ANTINEOPLASTIC AGENTS ON NARCOSIS].
    DIMEZZA F
    Minerva Anestesiol; 1964 Dec; 30():511-7. PubMed ID: 14267928
    [No Abstract]   [Full Text] [Related]  

  • 18. EXPERIMENTAL CHEMOTHERAPY STUDIES. IV. THE PROTECTIVE ACTION OF MERCAPTOALKYLAMINES AGAINST ALKYLATING AGENTS.
    RUTMAN RJ; LEWIS FS; PRICE CC
    Cancer Res; 1964 May; 24():626-33. PubMed ID: 14188465
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dangers of various therapeutic agents. Value of control of the blood formula].
    BENOIST F
    Sem Hop Ther Paris; 1961 Jul; 37():605-7. PubMed ID: 13867328
    [No Abstract]   [Full Text] [Related]  

  • 20. CHEMOTHERAPY OF BRAIN TUMORS. I. TRANSPLANTED MURINE EPENDYMOBLASTOMAS.
    SOLOWAY AH; MARK VH; DUKAT EG; KJELLBERG RN
    Cancer Chemother Rep; 1964 Mar; 36():1-4. PubMed ID: 14152269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.